Prognostic significance of spontaneous antibody responses against tumor-associated antigens in malignant melanoma patients-Reference-Cited by-同舟云学术

Prognostic significance of spontaneous antibody responses against tumor-associated antigens in malignant melanoma patients

Published:2014-05-28 Issue:1 Volume:136 Page:138-151
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Zörnig Inka¹,Halama Niels¹,Lorenzo Bermejo Justo²,Ziegelmeier Claudia¹,Dickes Elke³,Migdoll Alexander¹,Kaiser Iris¹,Waterboer Tim⁴,Pawlita Michael⁴,Grabe Niels¹,Ugurel Selma⁵,Schadendorf Dirk⁶,Falk Christine⁷,Eichmüller Stefan B.³,Jäger Dirk¹

Affiliation:

1. Department of Medical Oncology; National Center for Tumor Diseases; Internal Medicine VI; Heidelberg University Hospital; Heidelberg Germany

2. Institute of Medical Biometry and Informatics; University of Heidelberg; Heidelberg Germany

3. Division of Translational Immunology; German Cancer Research Center, DKFZ; Heidelberg Germany

4. Division of Genome Modifications and Carcinogenesis; German Cancer Research Center, DKFZ; Heidelberg Germany

5. Department of Dermatology; University of Würzburg; Würzburg Germany

6. Department of Dermatology; University Hospital Essen; Essen Germany

7. Institute for Transplant Immunology; IFB-Tx; Hannover Medical School; Hannover Germany

Funder

Tumorzentrum Heidelberg/Mannheim

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference39 articles.

1. Prospective randomized multicenter adjuvant dermatologic cooperative oncology group trial of low-dose interferon alfa-2b with or without a modified high-dose interferon alfa-2b induction phase in patients with lymph node-negative melanoma;Hauschild;J Clin Oncol,2009

2. Advanced malignant melanoma: immunologic and multimodal therapeutic strategies;Halama;J Oncol,2010

3. Prognostic significance of autoimmunity during treatment of melanoma with interferon;Gogas;N Engl J Med,2006

4. NY-BR-1 is a differentiation antigen of the mammary gland;Jager;Appl Immunohistochem Mol Morphol,2007

5. Humoral and cellular immune responses against the breast cancer antigen NY-BR-1: definition of two HLA-A2 restricted peptide epitopes;Jager;Cancer Immun,2005

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New AI-algorithms on smartphones to detect skin cancer in a clinical setting—A validation study;PLOS ONE;2023-02-15

2. Autoantibodies as Diagnostic Cancer Biomarkers;Handbook of Cancer and Immunology;2023

3. Multiplex flow cytometry-based assay for quantifying tumor- and virus-associated antibodies induced by immunotherapies;Frontiers in Immunology;2022-11-16

4. Systemic T-cell and humoral responses against cancer testis antigens in hepatocellular carcinoma patients;OncoImmunology;2022-10-05

5. A B‐cell or a key player? The different roles of B‐cells and antibodies in melanoma;Pigment Cell & Melanoma Research;2022-03-04